Drugmakers Ducked $1.3B In Medicaid Rebates, OIG Says
Drugmakers may have avoided paying $1.3 billion in Medicaid rebates by misclassifying a handful of innovator drugs as generics in recent years, the Office of Inspector General for the U.S. Department...To view the full article, register now.
Already a subscriber? Click here to view full article